Clinical Trials Logo

Clinical Trial Summary

Comparison of the magnesium level in difference continuous rate in women who were diagnosed severe pre-eclampsia obese


Clinical Trial Description

Magnesium sulfate is, generally, applied in order to alleviate or to avoid seizures. It can be administered according to many medical approaches. Nevertheless, at Rajavithi Hospital, the recommended administration of magnesium sulfate is 4 grams for loading dose in 15 minutes, followed by 2 grams for maintenance dose per hour (Zudpan regimen). The therapeutic index of magnesium is in the range of 4.8-8.4 mg/dL. After that, the level of magnesium sulfate will be evaluated every 4 or 6 hours.

At Rajavithi Hospital, there are a lot of patients having pre-eclampsia symptom and many patients, who were received magnesium sulfate in the treatment, having the level of magnesium sulfate lower than the therapuetic level and needed to increase the maintenance dose to 2.5 grams/hour. Therefore, this work aims to studying the amount of magnesium sulfate administered to pregnant woman with pre-eclampsia symptom who possess high body mass index (BMI), especially for BMI greater than or equal to 30 kg/m2. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03661775
Study type Interventional
Source Rajavithi Hospital
Contact
Status Completed
Phase N/A
Start date September 30, 2018
Completion date May 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT02164370 - Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach N/A
Recruiting NCT06219109 - Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia
Not yet recruiting NCT06385600 - Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia. N/A
Recruiting NCT05283473 - Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe Preeclampsia
Completed NCT01766089 - Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery Phase 2
Completed NCT06126068 - Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia. N/A
Recruiting NCT05176652 - Ultrasonographic Diameter of Optic Nerve Sheath in Fluid Assessment in Severe Preeclamptic Patients
Not yet recruiting NCT02314286 - Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery Phase 1/Phase 2
Completed NCT05310929 - Nitroglycerin Versus Labetalol in Acute Severe Pre-eclampsia N/A